195 related articles for article (PubMed ID: 21596083)
1. Multistrain genome analysis identifies candidate vaccine antigens of Anaplasma marginale.
Dark MJ; Al-Khedery B; Barbet AF
Vaccine; 2011 Jul; 29(31):4923-32. PubMed ID: 21596083
[TBL] [Abstract][Full Text] [Related]
2. Identification of Anaplasma marginale outer membrane protein antigens conserved between A. marginale sensu stricto strains and the live A. marginale subsp. centrale vaccine.
Agnes JT; Brayton KA; LaFollett M; Norimine J; Brown WC; Palmer GH
Infect Immun; 2011 Mar; 79(3):1311-8. PubMed ID: 21189322
[TBL] [Abstract][Full Text] [Related]
3. Anaplasma marginale outer membrane protein vaccine candidates are conserved in North American and South African strains.
Hove P; Brayton KA; Liebenberg J; Pretorius A; Oosthuizen MC; Noh SM; Collins NE
Ticks Tick Borne Dis; 2020 Jul; 11(4):101444. PubMed ID: 32336660
[TBL] [Abstract][Full Text] [Related]
4. Molecular conservation of MSP4 and MSP5 in Anaplasma marginale and A. centrale vaccine strain.
Molad T; Brayton KA; Palmer GH; Michaeli S; Shkap V
Vet Microbiol; 2004 May; 100(1-2):55-64. PubMed ID: 15135513
[TBL] [Abstract][Full Text] [Related]
5. Subdominant Outer Membrane Antigens in Anaplasma marginale: Conservation, Antigenicity, and Protective Capacity Using Recombinant Protein.
Ducken DR; Brown WC; Alperin DC; Brayton KA; Reif KE; Turse JE; Palmer GH; Noh SM
PLoS One; 2015; 10(6):e0129309. PubMed ID: 26079491
[TBL] [Abstract][Full Text] [Related]
6. Subdominant antigens in bacterial vaccines: AM779 is subdominant in the Anaplasma marginale outer membrane vaccine but does not associate with protective immunity.
Albarrak SM; Brown WC; Noh SM; Reif KE; Scoles GA; Turse JE; Norimine J; Ueti MW; Palmer GH
PLoS One; 2012; 7(9):e46372. PubMed ID: 23029498
[TBL] [Abstract][Full Text] [Related]
7. Identification of novel antigenic proteins in a complex Anaplasma marginale outer membrane immunogen by mass spectrometry and genomic mapping.
Lopez JE; Siems WF; Palmer GH; Brayton KA; McGuire TC; Norimine J; Brown WC
Infect Immun; 2005 Dec; 73(12):8109-18. PubMed ID: 16299305
[TBL] [Abstract][Full Text] [Related]
8. Immunogenicity of hypothetical highly conserved proteins as novel antigens in Anaplasma marginale.
Nuñez PA; Moretta R; Ruybal P; Wilkowsky S; Farber MD
Curr Microbiol; 2014 Mar; 68(3):269-77. PubMed ID: 24126603
[TBL] [Abstract][Full Text] [Related]
9. Rapid and long-term disappearance of CD4+ T lymphocyte responses specific for Anaplasma marginale major surface protein-2 (MSP2) in MSP2 vaccinates following challenge with live A. marginale.
Abbott JR; Palmer GH; Kegerreis KA; Hetrick PF; Howard CJ; Hope JC; Brown WC
J Immunol; 2005 Jun; 174(11):6702-15. PubMed ID: 15905510
[TBL] [Abstract][Full Text] [Related]
10. Differential expression and sequence conservation of the Anaplasma marginale msp2 gene superfamily outer membrane proteins.
Noh SM; Brayton KA; Knowles DP; Agnes JT; Dark MJ; Brown WC; Baszler TV; Palmer GH
Infect Immun; 2006 Jun; 74(6):3471-9. PubMed ID: 16714578
[TBL] [Abstract][Full Text] [Related]
11. Concomitant infection of cattle with the vaccine strain Anaplasma marginale ss centrale and field strains of A. marginale.
Shkap V; Leibovitz B; Krigel Y; Molad T; Fish L; Mazuz M; Fleiderovitz L; Savitsky I
Vet Microbiol; 2008 Aug; 130(3-4):277-84. PubMed ID: 18387757
[TBL] [Abstract][Full Text] [Related]
12. Distinctly different msp2 pseudogene repertoires in Anaplasma marginale strains that are capable of superinfection.
Rodríguez JL; Palmer GH; Knowles DP; Brayton KA
Gene; 2005 Nov; 361():127-32. PubMed ID: 16202540
[TBL] [Abstract][Full Text] [Related]
13. Immunogenicity of Anaplasma marginale type IV secretion system proteins in a protective outer membrane vaccine.
Lopez JE; Palmer GH; Brayton KA; Dark MJ; Leach SE; Brown WC
Infect Immun; 2007 May; 75(5):2333-42. PubMed ID: 17339347
[TBL] [Abstract][Full Text] [Related]
14. Immunogenicity of Outer Membrane Proteins VirB9-1 and VirB9-2, a Novel Nanovaccine against Anaplasma marginale.
Zhao L; Mahony D; Cavallaro AS; Zhang B; Zhang J; Deringer JR; Zhao CX; Brown WC; Yu C; Mitter N; Middelberg AP
PLoS One; 2016; 11(4):e0154295. PubMed ID: 27115492
[TBL] [Abstract][Full Text] [Related]
15. Anaplasma marginale superinfection attributable to pathogen strains with distinct genomic backgrounds.
Vallejo Esquerra E; Herndon DR; Alpirez Mendoza F; Mosqueda J; Palmer GH
Infect Immun; 2014 Dec; 82(12):5286-92. PubMed ID: 25287920
[TBL] [Abstract][Full Text] [Related]
16. Selection for simple major surface protein 2 variants during Anaplasma marginale transmission to immunologically naïve animals.
Palmer GH; Futse JE; Leverich CK; Knowles DP; Rurangirwa FR; Brayton KA
Infect Immun; 2007 Mar; 75(3):1502-6. PubMed ID: 17178787
[TBL] [Abstract][Full Text] [Related]
17. Expression of major surface protein 2 variants with conserved T-cell epitopes in Anaplasma centrale vaccinates.
Shkap V; Molad T; Brayton KA; Brown WC; Palmer GH
Infect Immun; 2002 Feb; 70(2):642-8. PubMed ID: 11796593
[TBL] [Abstract][Full Text] [Related]
18. Co-infections with multiple genotypes of Anaplasma marginale in cattle indicate pathogen diversity.
Hove P; Chaisi ME; Brayton KA; Ganesan H; Catanese HN; Mtshali MS; Mutshembele AM; Oosthuizen MC; Collins NE
Parasit Vectors; 2018 Jan; 11(1):5. PubMed ID: 29298712
[TBL] [Abstract][Full Text] [Related]
19. Cloning, sequencing and antigenic characterization of rVirB9 of Anaplasma marginale isolated from Paraná State, Brazil.
Vidotto MC; Venâncio EJ; Vidotto O
Genet Mol Res; 2008; 7(2):460-6. PubMed ID: 18561379
[TBL] [Abstract][Full Text] [Related]
20. Cross-protection between geographically distinct Anaplasma marginale isolates appears to be constrained by limited antibody responses.
Kenneil R; Shkap V; Leibovich B; Zweygarth E; Pfister K; Ribeiro MF; Passos LM
Transbound Emerg Dis; 2013 Nov; 60 Suppl 2():97-104. PubMed ID: 24589108
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
